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Background: BACE1 is one of the two enzymes that cleave amyloid precursor protein to generate Alzheimer's
disease (AD) beta amyloid peptides. It is widely believed that BACE1 initiates APP processing in endosomes, and in
the brain this cleavage is known to occur during axonal transport of APP. In addition, BACE1 accumulates in
dystrophic neurites surrounding brain senile plaques in individuals with AD, suggesting that abnormal
accumulation of BACE1 at presynaptic terminals contributes to pathogenesis in AD. However, only limited
information is available on BACE1 axonal transport and targeting.
Results: By visualizing BACE1-YFP dynamics using live imaging, we demonstrate that BACE1 undergoes bi-directional
transport in dynamic tubulo-vesicular carriers along axons in cultured hippocampal neurons and in acute hippocampal
slices of transgenic mice. In addition, a subset of BACE1 is present in larger stationary structures, which are active
presynaptic sites. In cultured neurons, BACE1-YFP is preferentially targeted to axons over time, consistent with
predominant in vivo localization of BACE1 in presynaptic terminals. Confocal analysis and dual-color live imaging
revealed a localization and dynamic transport of BACE1 along dendrites and axons in Rab11-positive recycling
endosomes. Impairment of Rab11 function leads to a diminution of total and endocytosed BACE1 in axons,
concomitant with an increase in the soma. Together, these results suggest that BACE1 is sorted to axons in endosomes
in a Rab11-dependent manner.
Conclusion: Our results reveal novel information on dynamic BACE1 transport in neurons, and demonstrate that
Rab11-GTPase function is critical for axonal sorting of BACE1. Thus, we suggest that BACE1 transcytosis in endosomes
contributes to presynaptic BACE1 localization.
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A transmembrane aspartyl protease, termed β-site APP
cleaving enzyme 1 (BACE1), initiates Alzheimer's disease
(AD) β-amyloid (Aβ) production by sequential proteoly-
sis of amyloid precursor protein (APP) [1-5]. The release
of Aβ from its precursor involves initial processing by
BACE1 to release the APP ectodomain, followed by intra-
membrane proteolysis by γ-secretase [6]. Aβ is the major
component of cerebral amyloid plaques in brains of aged
individuals and those with AD. Several lines of evidence
suggest that Aβ plays a central role in AD pathogenesis.* Correspondence: gopal@uchicago.edu
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article, unless otherwise stated.For example, familial AD-linked mutations near the
amino terminus of the Aβ region in APP, found in two
Swedish families, cause AD by significantly increasing
Aβ production due to enhanced BACE1 cleavage of APP
[7-9]. Moreover, a single amino acid substitution adjacent
to the BACE1 cleavage site of APP, which significantly re-
duces BACE1 cleavage and Aβ peptide generation in cul-
tured cells, has been recently found to protect against
disease onset as well as cognitive decline in the elderly
without AD [10].
APP and BACE1 are type I transmembrane proteins
that undergo secretory and endocytic trafficking. How-
ever, in cultured cell lines and primary neurons, only a
subset of full-length APP is processed to generate Aβ.
This implies either BACE1 cleavage of APP is rather in-
efficient or that BACE1 has limited access to APP due toCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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stricted localization in intracellular organelles. Over the
years, non-neuronal cells were used as experimental sys-
tems to characterize the cellular organelles and sorting
pathways involved in amyloidogenic processing of APP.
Most studies recognize the importance of endocytic traf-
ficking of APP for Aβ production [reviewed in [6,11,12].
This notion is in agreement with the predominant steady-
state localization of BACE1 in endocytic organelles, and its
trafficking and recycling between the plasma membrane
and endosomes [1,13,14]. Moreover, BACE1 activity has
a low pH optimum in vitro [1], supporting a model
where APP cleavage by BACE1 occurs in acidic intracel-
lular organelles such as the endosomes. Indeed, siRNA
knockdown of Golgi-associated, γ-adaptin homologous,
ADP-ribosylation factor-interacting proteins enhance
BACE1 localization in early endosomes and a concomi-
tant increase in Aβ secretion [15-17]. Finally, membrane
targeting of a BACE1 transition-state inhibitor to endo-
somal organelles by linking it to a sterol moiety effi-
ciently reduced BACE1 activity as compared with the
free inhibitor [18].
In the mouse brain, ~70% of Aβ released into the intersti-
tial fluid requires ongoing endocytosis, and synaptic activity
regulates the vast majority of this endocytosis-dependent
Aβ production [19,20]. The underlying mechanism likely
involves activity-dependent regulation of endocytic traffic-
king of APP as well as its secretases [21]. Neuronal
endosomes are not only found in the soma but are dis-
tributed throughout the dendrites and axons where
they undergo bidirectional transport, adding to the
complexity of the trafficking mechanisms [22]. Indeed,
APP undergoes BACE1-mediated cleavage during an-
terograde axonal transport, and Aβ can be generated
and released at or near presynaptic sites in vivo [19,23-27].
BACE1 has been reported to localize in dendrites and
axons in cultured neurons and in the brain [21,28-32].
Axonal BACE1 localization is significant because abnor-
mal accumulation of BACE1 in axon terminals has been
documented in the brains of individuals afflicted with AD.
This later finding raises the possibility that local elevation
in BACE1 processing could contribute to amyloid bur-
den in AD [30,33]. However, the molecular mechanisms
responsible for axonal sorting of BACE1 have not been
fully explored.
Here, we used live-cell imaging to characterize dy-
namic BACE1 transport in hippocampal neurons in vitro
and in brain slices in situ. We report BACE1 colocaliza-
tion and dynamic transport in recycling endosomes
within the dendrites and axons of cultured hippocampal
neurons. Interestingly, our results show that efficient
axonal sorting of BACE1 requires Rab11 activity. To-
gether, these findings provide the first demonstration of
dynamic BACE1 transport in hippocampal neurons insitu and the involvement of neuronal recycling endo-
somes in axonal sorting of BACE1.
Results
Axonal transport and presynaptic localization of BACE1 in
hippocampal mossy fibers
In the mouse brain, BACE1 exhibits prominent lo-
calization in the stratum lucidum of the hippocampus,
composed of axons and presynaptic terminals of mossy
fibers from granule cells in the dentate gyrus, and is
only weakly detected in dendrites [28,30,33]. Although
endogenous BACE1 is not detected along the axons
(Figure 1C), localization of BACE1 in large terminals
of hippocampal mossy fibers suggests that BACE1 traf-
fics to mossy fiber terminals by axonal transport. To
visualize dynamic BACE1 axonal transport in mossy
fibers, we generated bigenic mice in which yellow fluor-
escent protein-tagged BACE1 (BACE1-YFP) is inducibly
expressed under the control of the forebrain-specific
CaMKIIα promoter (Figure 1A and 1B). In control ex-
periments, we confirmed that BACE1-YFP chimeric
protein is able to process APP with efficiencies similar
to wild-type BACE1 [34]. Similar to endogenous BACE1
localization, BACE1-YFP fluorescence in brains of bi-
genic mice was prominent within the hippocampal
mossy fibers. A subset of BACE1-YFP fluorescence ap-
peared in punctate structures, which colocalized with
the presynaptic marker synaptophysin (Figure 1C). In
addition, BACE1-YFP fluorescence was visible along the
axons, and showed partial colocalization with neurofila-
ment (Figure 2A). Thus, similar to endogenous BACE1,
transgene-derived BACE-YFP is able to reach the pre-
synaptic terminals. Since BACE1-YFP is overexpressed a
few fold over endogenous levels, there is likely more
BACE1-YFP in transit along hippocampal mossy fibers,
which could be seen as axonal localization.
In order to visualize dynamic BACE1 axonal transport in
the mossy fiber axons, acute hippocampal slices of bigenic
mice were maintained at 30°C and live imaging was per-
formed. Multi-photon confocal imaging of the stratum
lucidum revealed BACE1-YFP fluorescence along the
mossy fibers within stationary structures and in tubulo-
vesicular carriers, which displayed alternating dynamic
movement and pausing behavior (Figures 2B and 2C,
Additional file 1). Kymographs were generated to analyze
BACE1-YFP transport dynamics. Transport of BACE1-YFP
along the mossy fiber axons could be observed in both the
anterograde and retrograde directions (away from and to-
wards the dentate gyrus hilus, respectively) with velocities
ranging from 0.1 – 0.7 μm/sec (Figure 2D). The mean ve-
locities for anterograde and retrograde movement of
BACE1-YFP-containing carriers were very similar (an-
terograde 0.325 ± 0.013 μm/sec, n = 137; retrograde
0.330 ± 0.016 μm/sec, n = 109). Importantly, these results
Figure 1 Axonal and presynaptic localization of BACE1-YFP in hippocampal mossy fibers of transgenic mice. (A) Schematic structure of tetO
BACE1-YFP transgene. (B) BACE1 expression in mouse forebrain lysates from bigenic BACE1-YFP (Tg BACE1-YFP), CamKIIα-tTA, non-transgenic (WT),
and BACE1−/− mice was analyzed by immunoblotting with mAb 3D5. (C) Localization of endogenous BACE1 and BACE1-YFP in presynaptic terminals
of the mouse brain hippocampal mossy fibers (MF). Top, non-transgenic mouse brain stained with anti-BACE1 mAb 3D5. 3 month-old non-transgenic
(top panel) or Tg BACE1-YFP mouse brains (bottom) were stained with antibodies against synaptophysin, and MAP2 and were analyzed by confocal
microscopy. Neuronal cell bodies in dentate gyrus (DG) were only weakly positive for BACE1-YFP.
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Figure 2 Dynamic transport of BACE1-YFP in hippocampal mossy fibers of Tg BACE1-YFP mice. (A) Tg BACE1-YFP brain stained with
anti-neurofilament NFT160 mAb. Note the prominent localization of BACE1-YFP in axons of hippocampal mossy fibers (MF). Nuclei of neuronal cell
bodies were labeled using DAPI staining. (B) Representative 2-photon confocal image of YFP fluorescence in Tg BACE1-YFP hippocampal brain
slice acquired near the region used for time-lapse imaging depicted in (B). MF, Mossy fibers. Note BACE1-YFP fluorescence in puncta of dendrites
and in the soma of a few CA3 neurons. (C) Time-lapse images of hippocampal slices from Tg BACE1-YFP were acquired at 30°C on a multiphoton
confocal microscope at the rate of 0.8 frames/sec for 4 min. Montage of representative images from Additional file 1, and corresponding kymographs
are shown. Arrowheads indicate the movement of BACE1-positive vesicular/tubular carriers away from the DG (anterograde) or toward the DG
(retrograde). (D) Maximum velocities of BACE1-YFP carriers (n = 136 anterograde; n = 113 retrograde; 8 brain slices from 3 BACE1-YFP bigenic mice
imaged) were quantified from kymographs and plotted as a histogram.
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port of BACE1 in mature CNS neurons in situ.
Axonal localization and transport of BACE1 in cultured
hippocampal neurons
The prominent presynaptic terminal localization of en-
dogenous as well as transgene-derived BACE1 in hippo-
campal mossy fiber terminal fields suggested the possibility
that BACE1 might undergo polarized sorting. However,
BACE1 has been previously reported to localize in neuronal
soma, dendrites, and axons of neurons in human brain
[4,34], and in cultured neurons [21,28-31,35]. In our experi-
ments, BACE1-YFP localization could be readily detected
both in dendrites and axons of cultured DIV5 hippocampal
neurons following overnight expression (Figure 3A). We
reasoned that subtle differences in the biosynthetic level of
BACE1 and the efficiency of the transport machinery in-
volved in BACE1 transport could account for these appar-
ent discrepancies. If this were the case, high-level transient
protein overexpression in the first one or two days follow-
ing transfection could be in excess over the trafficking
modulators, and might not be representative of the steady-
state BACE1 localization in cultured hippocampal neurons.
Therefore, we decided to observe BACE1 distribution sev-
eral days after transfection to assess whether or not there is
preferential axonal localization of BACE1 in cultured hip-
pocampal neurons. To this end, we co-transfected DIV5
neurons with BACE1-YFP and Cerulean and observed
them after 1, 3 and 5 days of expression (Figure 3A). We
used MAP2 staining to distinguish dendrites and axons. In
each transfected neuron, we measured the average fluores-
cence intensities of BACE1-YFP and Cerulean, along 1
pixel-wide line segments traced on 2–3 representative sec-
tions of dendrites and axons, and calculated the raw axon:
dendrite ratios. Then we divided the raw axon:dendrite ra-
tio of BACE1 by the raw axon:dendrite ratio of Cerulean
(which represents non-polarized localization of a cytosolic
protein) [36]. This normalization permits one to easily in-
terpret the data because a normalized ratio of >1 indicates
preferential axonal targeting, <1 indicates preferential den-
dritic localization, and a ratio of 1 indicates no preference
between localization in the axon or dendrite. Interestingly,
we found that the axon:dendrite ratio of BACE1-YFP sig-
nificantly increased in the days following transfection whilein the same neurons the axon:dendrite ratio of Cerulean is
not significantly different (Figure 3B). These results indicate
a preference for axonal BACE1-YFP targeting over time in
cultured hippocampal neurons, consistent with the in vivo
BACE localization in mossy fiber terminals.
To further analyze neuronal BACE1 localization and
trafficking, we transfected cultured primary mouse hippo-
campal neurons with BACE1-YFP on DIV11 and analyzed
them after 24–48 h. By performing live-cell imaging of
neurons maintained at 37°C, we found that axonal BACE1-
YFP resided within stationary structures as well as in
tubulo-vesicular carriers, which underwent bidirectional
transport (Figure 4A and 4C, Additional file 2). The axonal
transport speeds of individual BACE1-YFP carriers varied
greatly, but the mean anterograde and retrograde velocities
were very similar (anterograde 0.561 ± 0.032 μm/sec, n =
104; retrograde 0.529 ± 0.028 μm/sec, n = 83) (Figure 4B).
The transport dynamics of BACE1-YFP are in general
agreement with previously described fast axonal transport
of syntaxin 13, which ranged from 0.2 – 0.53 μm/sec [37].
Similar to our observations in hippocampal slices, we ob-
served saltatory movement of BACE1-YFP carriers charac-
terized by bursts of rapid movement alternating with
periods of brief pause. In addition, several transport ve-
sicles changed their direction of movement, sometimes
more than once, after short pauses (Figure 4A and 4C,
Additional file 2). Together, the data from acute hippo-
campal slices and cultured hippocampal neurons indicate
that a significant fraction of BACE1-YFP undergoes dy-
namic axonal transport.
In both acute hippocampal slices and cultured neurons,
a fraction of BACE1-YFP fluorescence remained stationary
for prolonged periods, and dynamic anterograde and
retrograde carriers often paused at these sites along the
axons (Figures 2C and 4A, Additional files 1 and 2).
Because a significant amount of endogenous BACE1 ex-
hibits presynaptic localization in hippocampal mossy fi-
bers (Figure 1C), we sought to determine whether the
stationary BACE1-YFP fluorescence represented presynap-
tic BACE1 localization. Live-cell imaging and kymograph
analysis of transfected neurons showed that most, if not
all, “stationary” BACE1-YFP fluorescence correspon-
ded to presynaptic sites marked by the accumulation
of co-transfected synaptophysin-cerulean (Figure 4D,
Figure 3 Preferential axonal targeting of BACE1-YFP over time after transfection in cultured hippocampal neurons. (A) Cultured
hippocampal neurons were co-transfected with plasmids expressing BACE1-YFP and Cerulean on DIV5 (when they have already developed dendrites
and long axons) and polarized distribution of BACE1-YFP was analyzed after 1, 3, and 5 days of transgene expression. Representative images of
BACE1-YFP distribution neurons 1 or 5 days after transfection are shown. MAP2 staining was used to identify dendrites and, by exclusion, axons
(arrowheads). (B) Mean axon-to-dendrite fluorescence intensity ratios were calculated for BACE1-YFP and Cerulean along major axon and dendrite
segments in co-transfected neurons analyzed after 1, 3, and 5 days of transgene expression (n = 23-28 neurons each imaged from four coverslips per
time point, two independent cultures).
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Figure 4 Characterization of dynamic BACE1 axonal transport and localization in functional synapses in cultured hippocampal neurons.
(A-C) Axonal transport of BACE1-YFP. (A) Time-lapse images of transfected neurons (DIV12-13) were acquired at the rate of 1 frame/sec for
3–5 min. A representative frame and the kymograph of the image series corresponding to Additional file 2 are shown. (B) Maximum velocities
of vesicles moving away (anterograde, n = 106) or toward (retrograde, n = 83) the cell body were quantified from kymographs of multiple axons
imaged from five independent cultures and plotted. (C) Representative image montages of time-lapse sequences from a segment of the axon
shown in Additional file 2 depict dynamic transport of BACE1-containing vesicles and tubulo-vesicular structures. Vesicles containing BACE1-YFP
are transported in the anterograde (left panels) or the retrograde (right panels); several BACE1-positive structures also remain stationary (indicated
by a green asterisks). Note the anterograde BACE1-containing vesicles emerging from the stationary larger vesicular structure. (D) Presynaptic
localization of BACE1 in cultured hippocampal neurons. Live-cell images from a transfected neuron (DIV14) show colocalization of BACE1-YFP
with synaptophysin-Cerulean. Sequential time-lapse images were acquired on the same axon (Additional file 3), and the dynamics of BACE1 and
synaptophysin were analyzed by generating kymographs. Note that the large, stationary, BACE1-containing pleomorphic structures are positive
for synaptophysin. (E) Localization of BACE1-Cerulean (BACE1-Cer) in functional synapses of DIV13 neurons labeled with FM1-43 (arrowheads).
A kymograph of BACE1-Cer dynamics in the same axonal segment is shown in the bottom panel. Note that BACE1-Cer remains stationary
(arrowheads) in structures that overlap with FM1-43 labeled synapses.
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presynaptic sites, we labeled live DIV14 neurons with the
fluorescent styryl pyridinium dye FM1-43, which is widely
used to visualize synaptic vesicle recycling [38]. FM1-43
uptake studies in live neurons transfected with BACE1-
Cerulean confirmed that stationary BACE1 fluorescence
co-localized with FM1-43 fluorescence, indicating that a
subset of axonal BACE1 is present in functional synapses
(Figure 4E). Together, these results show that BACE1 under-
goes dynamic axonal transport in hippocampal slices and in
cultured hippocampal neurons, and both endogenous and
transgenic BACE1 localize to presynaptic terminals.
BACE1-YFP is dynamically co-transported in Rab11-positive
recycling endosomes
As mentioned above, the dynamics of BACE1 axonal
transport is similar to what has been reported for syn-
taxin 13, a protein that localizes to recycling endo-
somes. Indeed, in transfected neurons BACE1-YFP
co-localized extensively with endogenous syntaxin 13
in dendrites and in axons (Figure 5A) confirming BACE1
localization in recycling endosomes. To confirm this fin-
ding, we assessed co-localization of BACE1-YFP with
Rab11, a GTPase that regulates slow recycling of many
endocytic cargos [39]. In neurons, Rab11b (the neuron-
specific Rab11 isoform) plays key roles in trafficking of
proteins such as AMPA receptors, Trk receptors and
N-Cadherin in recycling endosomes [40-42]. In co-
transfected neurons, BACE1-YFP extensively coloca-
lized with mCherry-Rab11b in dendritic spines, at the
bases of spines, and in dendritic shafts [Manders’ coeffi-
cient 0.66 ± 0.06], as well as along axons [0.38 ± 0.12]
(Figure 5B). To test if BACE1 is dynamically trans-
ported in Rab11b-positive vesicles in dendrites and
axons, we performed dual-color time-lapse imaging and
generated kymographs. This analysis revealed both a dy-
namic and stationary pool of Rab11b-positive structures.
Notably, carriers positive for both BACE1 and Rab11b
underwent dynamic bidirectional co-transport in dendritesand axons (Figure 5C, Additional file 4). Thus, in hippo-
campal neurons, BACE1 localizes to, and is dynamically
transported in, Rab11b-positive recycling endosomes along
dendrites and axons.
Axonal polarized sorting of BACE1 requires Rab11
GTPase activity
Rab11-positive endosomes meditate transcytosis of inter-
nalized Trk receptors in sympathetic neurons [41]. In
order to examine whether Rab11 plays a role in facilitating
polarized sorting of BACE1-YFP in axons of hippocampal
neurons, we overexpressed wild-type (WT) Rab11b or a
GDP-bound dominant-negative (DN) Rab11b mutant
(Rab11S25N) together with a BACE1-YFP modified at the
N-terminus with the 13-amino acid α-Bungaratoxin Bind-
ing Site (BBS) tag, termed BBS-BACE1-YFP. BBS-tagged
receptors have been shown to efficiently bind fluorescently
labeled α-bungarotoxin (BTX) in live neurons [43]. Re-
cently, we used this strategy to selectively label the inter-
nalized pool of BACE1 in dendrites and axons of
hippocampal neurons [34]. In neurons transfected with
Rab11b, we employed the BTX labeling method to label
internalized BACE1-YFP by incubating live neurons at
37°C in presence of Alexa-Fluor 647 labeled α-bungarotoxin
(AF647-BTX). After saturable labeling of internalized
BACE1 by 3–4 h of continuous AF647-BTX uptake, we
removed the remaining surface-bound AF647-BTX using
a brief acid wash in a low pH buffer and then quantified
the axon:dendrite ratios. BTX-labeling of internalized
BACE1 was observed in neurons transfected with empty
vector, wt Rab11b, and Rab11bS25N (Figure 6A). However,
axon:dendrite ratio quantifications revealed a significant
decrease in the levels of total (YFP fluorescence) as well as
internalized BACE1 (BTX fluorescence) in axons of neu-
rons expressing Rab11bS25N (Figure 6A, 6B and 6D). We
next measured the ratio of the mean fluorescence intensity
of the cell body and dendrites and found an increase of
BACE1 cell body:dendrite ratio in neurons expressing
Rab11bS25N (Figures 6E and 6F).
Figure 5 (See legend on next page.)
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Figure 5 Localization and dynamic transport of BACE1 in recycling endosomes. (A) Colocalization of BACE1 with endogenous syntaxin 13
in dendrites and axons of cultured hippocampal neurons (DIV12). Insets show higher magnification of the boxed area. Images of the dendrites
were acquired by confocal microscopy and those of the axon were generated by deconvolution of widefield z-stacks. Dendrites and axons were
identified by the presence and absence of MAP2 staining, respectively. (B) Analysis of BACE1 colocalization with Rab11b in dendrites and axons.
DIV12 neurons co-transfected with BACE1-YFP and mCherry-Rab11b were immunostained for MAP2. Insets show higher magnification of the
area marked by a yellow arrowhead on a dendrite or the boxed area in an axon. Arrowheads indicate vesicles positive for BACE1 and Rab11b along
the axon. Manders’ coefficient of colocalization (M Coeff) is indicated (n = 7 neurons). (C) Visualization of BACE1-YFP and mCherry-Rab11b dynamic
co-transport by dual-color live cell imaging. Time-lapse images were acquired using the Dual-View two-channel simultaneous-imaging system at
the rate of 1 frame/sec for 3 min (Additional file 4). Kymograph analysis reveals bidirectional transport of BACE1 in Rab11b-positive endosomes
(yellow tracks in the overlay panels) in both dendrites and axons.
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pression caused an abnormal targeting or retention of
BACE1 in cellular organelles in the soma, we performed
colocalization analysis of internalized BACE1 with en-
dogenous markers of early endosomes (EEA1), recycling
endosomes (transferrin receptor; TfR), and lysosomesFigure 6 Rab11b GTPase activity regulates axonal targeting of BACE1
mCherry-Rab11b WT or Rab11bS25N dominant-negative mutant were labe
visualize internalized BACE1. Dendrites and axons were identified by MAP
total (YFP) and internalized BACE1 (BTX) fluorescence intensities in the sam
(rectangle boxes) of neurons shown in A. (C) Higher magnification of the cell b
fluorescence intensity ratios for total (YFP) and internalized BACE1 (BTX) were
vector, Rab11b WT or Rab11S25N (n = 14-15 neurons each). (E) Mean cell body
were quantified. Note that expression of Rab11S25N resulted in a significant de
the cell body.(LAMP1), visualized by immunofluorescence staining
and confocal microscopy (Figure 7A). We then calcu-
lated the Manders’ coefficient to quantify the extent of
colocalization. This analysis revealed no evidence of re-
tention of internalized BACE1 in early endosomes and
only a small, non-significant increase in localization in. (A) DIV12 neurons co-transfected with BBS-BACE1-YFP and
led with AF647-BTX uptake followed by an acid wash to selectively
2 immunostaining of fixed neurons. The pseudocolor images depict
e neuron. (B) Higher magnification of dendrite and axon segments
odies (square boxes) of neurons shown in A. (D) Mean axon-to-dendrite
quantified from individual neurons cotransfected with BACE1 and empty
-to-dendrite fluorescence intensity ratios for total and internalized BACE1
crease of axonal BACE1 localization and an increase of BACE1 levels in
Figure 7 Confocal analysis of internalized BACE1 localization in the soma of cultured hippocampal neurons. (A) Representative confocal
images of the cell bodies of neurons co-transfected with BBS-BACE1-YFP and the indicated mCherry-tagged Rab11b WT, Rab11S25N, or empty
vector constructs. Internalized BACE1 pool was labeled by AF647-BTX uptake, and the neurons were fixed following an acid wash to remove
remaining surface staining. Neurons were then immunostained with markers of early endosomes (EEA1), lysosomes (LAMP1) and recycling endosomes
(TfR), and analyzed by confocal microscopy. (B) The extent of colocalization between internalized BACE1 and endogenous organelle markers was
quantified in the cell bodies of neurons transfected with the indicated constructs (n = 6-10 neurons each). Note that BACE1 is still able to reach
TfR-positive recycling endosomes in the cell body after the overexpression of Rab11S25N.
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ternalized BACE1 in the soma were largely positive for the
recycling endosome marker TfR, regardless of the overex-
pression of wt Rab11b or Rab11bS25N (Figures 7A and 7B).
Thus, we conclude that internalized BACE1 is not grosslymislocalized in either early endosomes or lysosomes upon
the expression of Rab11bS25N dominant-negative mutant
(Figure 7B). These results indicate that Rab11b GTPase
activity does not play a major role in sorting of internal-
ized BACE1 to TfR-positive recycling endosomes in the
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ratio analysis revealed that Rab11 activity is required for
efficient axonal targeting of BACE1 (Figure 6D). Together,
these results suggest that following internalization BACE1
is targeted to axons in a Rab11-dependent manner.
Discussion
In this study, we generated transgenic mice expressing
BACE1-YFP, and for the first time, visualized BACE1 dy-
namic axonal transport in situ within the mossy fibers of
the hippocampus by multiphoton microscopy. Moreover,
we investigated the localization and trafficking of BACE1
by live-cell imaging in cultured hippocampal neurons.
The dynamic characteristics of BACE1 transport in hippo-
campal slices and in mature primary cultured hippocampal
neurons (DIV12-14) shared several similarities. In both
cases we observed two distinct pools of BACE1: a highly
dynamic pool of BACE1 found in tubulo-vesicular carriers
that were transported bi-directionally and consistent with a
microtubule-based transport mechanism; moreover, a sec-
ond pool of BACE1 found in stationary structures that were
relatively larger in size as compared with the motile car-
riers. FM-dye uptake studies revealed that stationary
BACE1-YFP fluorescence corresponds to active pre-
synaptic terminals. Finally, using immunofluorescence label-
ing and dual-color imaging, we demonstrate BACE1-YFP
localization and dynamic transport in Rab11-positive recyc-
ling endosomes. Expression of a dominant-negative Rab11
mutant causes accumulation of internalized BACE1 in the
soma concomitant with a loss of BACE1 levels in the axons,
consistent with BACE1 transcytosis from the somato-
dendritic compartments to the axons in endosomes.
In human brain, BACE1 can be observed by immuno-
staining in dendrites of CA1 neurons [34]. Interestingly,
in mouse brain, endogenous BACE1 is highly enriched
in hippocampal mossy fiber terminals, and only low
levels of BACE1 can be detected in the neuronal soma
and dendrites (Figure 1) [33,34]. These apparent differ-
ences likely represent the balance between the biosyn-
thetic level and the efficiency of the transport machinery
responsible for BACE1 trafficking. Thus, overexpression
of BACE1-YFP in cultured hippocampal neurons allows us
to appreciate dynamic sorting of BACE1 between dendrites
and axons, which is not possible to discern from steady-
state analysis of endogenous proteins that have reached
their preferred final destination. Indeed, our results on
BACE1 localization are analogous to what has been do-
cumented for the localization of kainate-type glutamate
receptor subunits GluK2 and GluK3. When analyzed by
immunohistochemistry, the distribution of GluK2 and
GluK3 is prominent at hippocampal mossy fiber synapses
in mouse brain [44]. However, detailed analysis of these
receptors by transfection in cultured hippocampal neurons
reveals a prominent dendritic localization and demonstratesthat the steady-state localization of kainate receptors is
achieved by dynamic activity-dependent polarized endocy-
tic sorting from the dendrites through recycling or degrada-
tive pathways [45,46]. The progressive increase in BACE1
levels in axons concomitant with its decrease in den-
drites over time following transfection suggest the exist-
ence of saturable mechanisms that mediate polarized
axonal sorting of BACE1 (Figure 3). Axonal sorting and
presynaptic localization of BACE1 are highly relevant
because of the recent identification of several presynaptic
proteins such as L1, CHL1, LRRN1, brain EGF-repeat con-
taining transmembrane protein, and neurexin-1a as neur-
onal BACE1 substrates [47,48]. Moreover, loss of BACE1
expression results in axon guidance defects in the hippo-
campus and the olfactory bulb [36,44,48].
Although the machinery and the molecular mecha-
nisms governing polarized sorting of proteins in neurons
needs to be further explored, the involvement of three
pathways for the axonal targeting of transmembrane
proteins has been suggested: 1) direct polarized delivery
of nascent proteins from the secretory pathway to the
dendrites or axons in TGN-derived vesicles, 2) non-
polarized delivery to dendrites and axons followed by se-
lective retrieval and retention involving endocytosis and
degradation pathways, 3) indirect polarized delivery via
endosomes, also called transcytosis, whereby nascent
proteins are first delivered to the somato-dendritic cell
surface, and then following endocytosis get routed to the
axons [22]. The extensive localization of BACE1 in
endosomes and the highly polarized axonal localization
of BACE1 in hippocampal mossy fibers ([34], Figures 1
and 5) suggest that the direct polarized delivery is un-
likely to play a major role in BACE1 axonal targeting.
The results detailed in this study suggest that BACE1
sorting to Rab11-positive recycling endosomes plays an
important role for further transport to the axons and
presynaptic terminals. First, BACE1 is efficiently sorted
in endosomes positive for three known markers of recyc-
ling endosomes: Rab11, syntaxin 13, and TfR [21,34].
Second, the dynamic characteristics of BACE1 transport in
hippocampal neurons, characterized by live-cell imaging,
are consistent with protein trafficking in recycling
endosomes [37], a conclusion supported by two-color im-
aging of BACE1 co-transport with Rab11 in dendrites and
axons (Figure 5, Additional file 4). Third, the impairment
of Rab11 activity by dominant-negative mutant expression
caused internalized BACE1 accumulation in the soma with
a concomitant decrease in axons. The accumulation of
internalized BACE1 in the soma and unperturbed relative
subcellular distribution in endosomes and lysosomes
(Figure 7) suggest that BACE1-containing vesicles are not
rerouted for lysosomal degradation when a block in recyc-
ling itinerary is imposed by DN Rab11 expression. Because
we have not found convincing evidence for the involvement
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soma and dendrites, we hypothesize that proper BACE1
sorting to axons and presynaptic terminals requires its
transcytosis in a Rab11-dependent manner rather than
aspecific sorting followed by selective retention/retrieval
mechanisms. Interestingly, BACE1 shows only partial colo-
calization with Rab11 in axons, when observed by immuno-
fluorescence staining or dual-color live imaging (Figure 5).
These findings suggest that in axons a subset of BACE1 is
sorted independent of Rab11-positive endosomes or Rab11
detaches from a subset of BACE1-positive vesicles. It will
be of interest to identify other trafficking adaptors that
regulate dynamic BACE1 transport in axons. In this re-
gard, we recently reported that loss of Eps15-homology-
domain containing 1 and 3 protein function in hippo-
campal neurons compromises dynamic axonal transport
and overall BACE1 levels in axons [34].
Thus far, only a few proteins have been characterized
to undergo neuronal somaodendritic-to-axonal trans-
cytosis; notable examples are the axonal cell adhesion
molecule L1/NgCAM [49], tropomyosin-related kinase
Trk receptors [41], and Contactin-associated protein 2,
Caspr2 [50]. In each case, it is clear that endosomal sort-
ing is required for axonal targeting, but the machinery
and the molecular players involved in achieving po-
larized sorting are not fully understood. Also, differences
could be already found between the steady-state localization
of these proteins suggesting the existence of different regu-
latory mechanisms in the transcytotic pathway. For ex-
ample, L1/NgCAM axonal surface expression is prominent
and highly polarized in transfected cultured neurons [49],
which is not the case for BACE1. In addition, L1/NgCAM
is sorted mainly in NEEP21-positive vesicles in soma/
dendrites before transcytosis, and shows only low levels of
colocalization with transferrin-positive recycling endosomes.
In contrast, a large fraction of BACE1 is found in recycling
endosomes positive for TfR and Rab11, with only a relatively
smaller fraction present in EEA1 or NEEP21-positive early
endosomes (Figure 5, [34]). Thus, it appears that L1/
NgCAM and BACE1 are subject to different the endo-
somal sorting steps prior to transcytosis. BACE1 sorting
in recycling endosomes and dynamics share similarities with
Trk receptors. Similar to BACE1 trafficking in hippocampal
neurons, TrkA is also dynamically co-transported in axons
in Rab11-positive vesicles and its trafficking in sympathetic
neurons also requires Rab11-GTPase activity for efficient
transcytosis [41]. It has been hypothesized that transcytosis
serves as a means to facilitate efficient axonal delivery of re-
ceptors in response to signals often involving ligand:receptor
interaction in presynaptic terminals as it is shown for TrkA
transcytosis mediated by nerve growth factor signaling [41].
Since BACE1 is the first reported enzyme to undergo trans-
cytosis, exploring potential signals that regulate BACE1
transcytosis would be of great interest especially for a betterunderstanding of the mechanism underlying its abnor-
mal accumulation in swollen presynaptic terminals in
Alzheimer’s disease. Since synaptic activity regulates BACE1
trafficking and APP processing [19-21] it is possible that
synaptic activity impairment observed in Alzheimer’s disease
could affect BACE1 transcytosis in a manner that promotes
its accumulation in dystrophic neurites, thus contributing to
local Aβ production near the presynaptic terminals.
Abnormalities of the endosomal system such as the fu-
sion of early and recycling endosomes have long been
implicated in Alzheimer’s disease pathogenesis (reviewed
in [11]). Interestingly, Rab11 was recently identified as
one of the two major regulators of Aβ production, in an
unbiased RNAi screen of human Rab GTPases and Rab
GTPase-activating proteins by Rajendran and colleagues
[51]. Overexpression of dominant-negative mutants of
Rab11a or Rab11b also reduced Aβ and sAPPβ levels sig-
nificantly. Moreover, siRNA knockdown of Rab11 expres-
sion in primary neurons significantly reduce sAPPβ and
Aβ levels demonstrating that Rab11 function is crucial for
β-cleavage and Aβ generation [51]. Our characterization
of Rab11 as a novel regulator of BACE1 axonal sorting in
neurons, along with the identification of Rab11 as a modula-
tor of Aβ production, raises the possibility that dysfunction
of Rab11 may underlie pathogenesis in a subset of sporadic
Alzheimer’s disease cases. Indeed, aberrant Rab11 trafficking
has been reported in Huntington's disease and contributes
to oxidative stress and neuronal cell death [52]. Future stud-
ies aimed at manipulating of polarized neuronal BACE1 traf-
ficking to assess potential modulation of Aβ production
in vivo would be necessary to evaluate if trafficking modula-
tion of BACE1 could serve as a therapeutic strategy in
Alzheimer’s disease to reduce cerebral amyloid burden.
Methods
cDNA constructs
The expression plasmids that encode BACE1-YFP and BBS-
BACE1-YFP (harboring the 13-amino acid α-Bungaratoxin
Binding Site) were generated as described in [34]. A similar
strategy was used to generate BACE1-Cerulean construct.
To generate mouse Rab11b expression plasmids, a mouse
brain PCR product that codes for amino acids 72 to 218
was exchanged for the corresponding region in HA-tagged
Rab11a WT and Rab11aS25N constructs [53]. The cDNA
inserts were then subcloned in-frame into the pmCherry-
C1 vector. All constructs were verified by sequencing.
pCS2-Cerulean was generated by subcloning the Cerulean
coding sequence downstream of the CMV promoter. The
Cerulean-tagged synaptophysin expression construct was
provided by Dr. Karen L. O'Malley.
Generation of BACE1-YFP transgenic mice
BACE1 transgenic mice were generated in which expres-
sion of BACE1-YFP is regulated by tetracycline [Tet-off
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with YFP through a 22-residue linker was subcloned into
the EcoRV site of the tetO promoter expression vector
pMM400 (gift of M. Mayford, The Scripps Research In-
stitute, La Jolla, CA). The tetO promoter BACE1-YFP
transgene was excised with NotI, purified and micro-
injected into single mouse embryos (Transgenic and
Targeted Mutagenesis Lab, NU). tetO promoter-BACE1-
YFP transgenic lines were established and bred with
CAMKIIα promoter-tTA transgenic mice (line B, gift of
M. Mayford). Bigenic tetO promoter-BACE1-YFP/Cam-
KIIα promoter tTA offspring were identified by PCR,
weaned and fed either normal mouse chow or chow con-
taining 200 mg/kg of doxycyline for 4 weeks. Expression
of the transgene varied from ~1.5 to >10-fold over en-
dogenous BACE1 (as assessed by Western blot analysis) in
bigenic mice derived from different tetO promoter-
BACE1-YFP lines, but the distribution and localization of
BACE1-YFP was similar. Animals from a high-expressor
line (#429) was used in this study due to it producing im-
ages with the greatest signal to noise ratio.
Immunohistochemistry and immunofluorescence staining
Brains were harvested from bigenic BACE1-YFP mice
(3-month) and WT littermates were fixed overnight at
4°C in 4% paraformaldehyde and cryoprotected in PBS
30% sucrose/PBS. Immunofluorescence staining was per-
formed on 40 μm coronal sections or 30 μm sagittal sec-
tions as described [30,55,56]. The following primary
antibodies were used: BACE1 rabbit mAb D10E5 (1:125;
Cell Signaling), synaptophysin pAb (1:75; R&D System),
polyclonal MAP2 (1:250, SantaCruz), MAP2 mAb (1:500;
gift of Dr. Lester Binder), and neurofilament mAb NFT160
(1:3,700; Sigma-Aldrich). Alexa Fluor 488-, 568-, or 647-
conjugated secondary antibodies (Molecular Probes)
were used for detection. Images were acquired on Zeiss
LSM 510 META laser scanning confocal microscope
(BACE1-YFP transgenic brain in Figures 1C and D) or
Leica SP5 II STED-CW Superresolution laser scanning
confocal microscope (Figure 1C), and processed using
ImageJ software.
Live imaging on hippocampal slices
Freshly harvested brains of bigenic mice were placed in
cold ACSF aerated with 95% CO2/5% O2 blood gas mixture
and cut into 500 μm horizontal slices. The slices were then
maintained at room temperature in a bath perfused with
aerated ACSF. For live-cell imaging, each slice was posi-
tioned on the microscope stage such that the dentate gyrus
was on the left side of the image, perfused with ACSF and
maintained at 30°C. Slices were excited at 920 nm with
Mai-Tai HP DeepSee-OL laser (Spectra-Physics, laser range
690–1040 nm) using a Olympus FV1000MPE multiphoton
confocal system mounted on a BX61WI frame. Imageswere acquired using 60X (NA 1.1) water immersion
objective at the rate of 0.8 frame/sec for 4 min.
Immunofluorescence staining and live cell imaging of
primary hippocampal neurons
Hippocampal neurons were cultured from E17 mouse em-
bryos as previously described [34,57]. Dissociated neurons
were cultured on poly-D-lysine-coated glass coverslips sus-
pended over a monolayer of primary astrocytes prepared
from P0-P2 mouse cortex. Cultures were maintained in
Neurobasal supplemented with B27 serum-free and
GlutaMAX-I supplement (Invitrogen). Neurons were trans-
fected with Lipofectamine2000 (Invitrogen) on DIV 5 and
fixed at various maturation stages in 4% paraformaldehyde
containing 4% sucrose. For live-cell imaging, neurons were
transfected on DIV11 and used between DIV12-14. The
coverslips were maintained in imaging medium (119 mM
NaCl, 2.5 mM KCl, 2 mM CaCl2, 2 mM MgCl2, 30 mM
D-glucose, and 25 mM HEPES; pH 7.4) during image ac-
quisition. Functional synapses were labeled in live DIV13
neurons transfected with BACE1-Cerulean by allowing
FM1-43 Dye uptake, essentially as described [58].
BTX uptake experiments to label internalized BACE1
were performed essentially as described [34]. Briefly,
AF647-conjugated BTX (Invitrogen) was added to the
culture medium (6.6 μg/ml final), at 37°C for 3 to 4 h.
Coverslips were washed with ice-cold Hanks' balanced
salt solution with 10 mM HEPES, pH 7.3, and BTX bound
to cell surface BACE1 was removed by incubation in an
acidic solution (0.5 M NaCl and 0.2 M acetic acid, pH 2.8)
for 2 min before fixation.
Fixed neurons on coverslips were quenched with
50 mM of NH4Cl for 10 min, permeabilized for 6 min
on ice with 0.2% Triton X-100, and blocked with 3%
BSA in PBS. The coverslips were incubated for 1 h at room
temperature with the primary antibodies diluted in PBS
containing 3% BSA: MAP2 mAb (1:5,000; Sigma), EEA1
(1:200; Millipore), Syntaxin 13 (1:1000; Synaptic Systems);
TfR mAb (C2F2, 1:250; Pharmingen), rat anti-LAMP1
(ID4B, 1:150; Developmental Studies Hybridoma Bank).
Subsequently, the coverslips were incubated with Alexa
555- or 647-conjugated secondary antibodies (Molecular
Probes) for 1 h at room temperature and mounted using
Permafluor (Thermo Fisher).
Image acquisition and analysis
Wide-field epifluorescence images of fixed neurons were
acquired as 200 nm z-stacks using 20X (NA 0.75) or
60X (NA 1.49) objectives. Confocal images were acquired
on a Leica SP5 II STED-CW Superresolution Laser
Scanning Confocal microscope using 10X (NA 0.4) and
100X (NA 1.4; zoom 2.5) objectives. Image stacks were
deconvolved using Huygens software (Scientific Volume
Imaging). Extended Depth of Field plugin of ImageJ was
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z-stacks [59]. Quantitative image analysis was performed
using Metamorph (Molecular Devices) and ImageJ [60]
softwares. Axonal and dendritic BACE1 fluorescence inten-
sities were quantified on 10X single plane images or 60X
z-stack projections of neurons using an established method
as described previously [34,61]. Briefly, the average fluores-
cence intensities were measured along 100–200 μm-long 1
pixel-wide line segments traced on 2–3 representative sec-
tions of dendrites and axons in each neuron using ImageJ.
The mean fluorescence intensity in the soma was quantified
by drawing a region around the soma. The average axon:
dendrite and cell body:dendrite ratios were calculated for
each neuron. Normalized axon:dendrite ratio was then cal-
culated by dividing the raw axon:dendrite ratio of BACE1
by axon:dendrite ratio of Cerulean in the same neuron [36].
Manders’ coefficient of colocalization of BACE1 with or-
ganelles markers or mcherry-Rab11b was calculated on
thresholded confocal 100X images of dendrites and cell
bodies, or 60X deconvolved z-stack projections of axons
(identified by the exclusion of MAP2 staining) using JACoP
ImageJ plugin [62].Live-cell imaging
Live-cell images were acquired on a motorized Nikon
TE 2000 microscope maintained at 37°C in a custom-
designed environment chamber, at the rate of 1 frame/
sec, using 60X (NA 1.49) objective and Cascade II:512
CCD camera (Photometrics). Dual-color imaging was
performed using the Dual View Imaging System (Optical
Insights, LLC). Image stacks were processed using ImageJ.
Kymographs were generated in Metamorph, and used to
determine the frequency and directionality of particle
movement, and to quantify maximum velocities of par-
ticles moving at the rate of >0.1 μm/sec.Statistical analysis
Each experiment was performed using at least three in-
dependent sets of cultures unless otherwise specified.
Data are presented as mean ± SEM. Statistical sig-
nificance was determined by t-tests (two groups) or
ANOVA (three or more groups) using GraphPad Prism
software and indicated the figures: * p < 0.05; ** p < 0.01;
*** p < 0.001; **** p < 0.0001; ns - non-significant.Additional files
Additional file 1: Time-lapse Analysis of Axonal Transport of BACE1
in Hippocampal Mossy Fibers. Acute hippocampal slices of BACE1-YFP
bigenic mice were maintained at 30°C by perfusion with ACSF, and imaged
on Olympus FV1000 MPE multiphoton confocal microscope under 920 nm
excitation. Time-lapse images of the hippocampal mossy fibers were
acquired at a rate of 0.8 frames/sec (4 μsec/pixel sampling speed) for 4 min,
and displayed at 15 frames/sec. BACE1-YFP containing carriers moving awayfrom the hilus (anterograde) or toward the hilus (retrograde) are shown.
Representative still images are shown in Figure 2C.
Additional file 2: Dynamic Axonal Transport of BACE1 in Cultured
Hippocampal Neurons. Hippocampal neurons transfected with BACE1-YFP
(DIV12) were monitored under a temperature-controlled environment at 37°C
on a Nikon TE 2000 microscope. Images were acquired at a rate of 1
frame/sec for 5 min, with an exposure time of 300 ms, and displayed at
10 frames/sec. Arrows indicate BACE1 anterograde (blue) and retrograde
transport (red). Representative still image and image montages are
shown in Figure 4A and 4C.
Additional file 3: Presynaptic Localization of BACE1. Hippocampal
neurons (DIV14) cotransfected with BACE1-YFP and Synaptophysin-Cerulean
were observed by live-cell imaging. Sequential time-lapse images were
acquired at a rate of 1 frame/sec for 3 min on the same axon, with an
exposure time of 300 ms, and displayed at 10 frames/sec. Arrowheads
point to stationary structures that contain BACE1 and synaptophysin.
The anterograde direction of movement is toward the right. Representative
still images are shown in Figure 4D.
Additional file 4: Dynamic Colocalization BACE1with Rab11b in
Dendrites and Axons. Hippocampal neurons (DIV14) cotransfected with
BACE1-YFP and mCherry-Rab11b were observed by live-cell imaging.
Dual-color time-lapse images of a dendritic branch and an axon were
acquired using the Dual View imaging system at a rate of 1 frame/sec
for 3 min, with an exposure time of 300 ms, and displayed at 7 frames/
sec. In the dendrite (top), bidirectional movement of a carrier containing
BACE1 and Rab11b, emerging from a larger stationary structure, which
also contains both the proteins, is indicated by a pink arrowhead; a rapidly
moving vesicle containing both BACE1 and Rab11 is indicated by a blue
arrowhead. In the axon (bottom), blue and pink arrowheads indicate rapidly
moving carriers that contain both the proteins. The anterograde direction of
movement is toward the right. Scale bar 20 μm. Representative kymographs
are shown in Figure 5C.
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